Alembic Pharma gets USFDA nod for Travoprost glaucoma drug
The U.S. FDA approval came for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution. File. | Photo Credit: Reuters Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution USP, 0.004% (ionic buffered solution). The approved…
Read More “Alembic Pharma gets USFDA nod for Travoprost glaucoma drug” »